Clinical inertia in people with type 2 diabetes: A retrospective cohort study of more than 80,000 people. Diabetes Care 2013;36:3411-3417

Diabetes Care

Volumn 37, Issue 5, 2014, Pages

  Esposito, Katherine ^a   Maiorino, Maria Ida ^a   Bellastella, Giuseppe ^a   Giugliano, Dario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

CLINICAL INERTIA; COHORT ANALYSIS; DYSLIPIDEMIA; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LETTER; MEDICAL PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; UNITED KINGDOM; DIABETES MELLITUS, TYPE 2; FEMALE; MALE;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE;

EID: 84899120595     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2511     Document Type: Letter

References (5)

1. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care 2013;36:3411-3417
2. Currie CJ, Gale EA, Poole CD. Estimation of primary care treatment costs and treatment efficacy for people with type 1 and type 2 diabetes in the United Kingdom from 1997 to 2007. Diabet Med 2010;27:938-948
3. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013;368:1613-1624
4. Giugliano D, Esposito K. Clinical inertia as a clinical safeguard. JAMA 2011;305:1591-1592
5. Esposito K, Ceriello A, Giugliano D. Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes? Endocrine 2013;44:343-345